Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents

Rheumatic Diseases Clinics of North America
Mary Anne Dooley, Ellen M Ginzler

Abstract

There has been unprecedented growth in new therapeutic approaches for the treatment of systemic lupus erythematosus (SLE). These approaches include re-evaluation of the doses and duration of therapy with traditional agents, including intravenous cyclophosphamide and azathioprine. Drugs that were developed for other uses are being applied to specific SLE manifestations, and have spurred larger scale trials for overall disease activity. In addition, several new agents show promise in clinical trials; many have safer toxicity profiles than do traditional therapies. Some of these agents have multiple immunomodulatory effects, whereas others interfere with a specific immunologic process in one of the pathogenetic pathways of SLE activity.

References

Oct 1, 1991·The American Journal of Medicine·M PetriM Hochberg
Mar 6, 1986·The New England Journal of Medicine·H A AustinJ L Decker
Jan 1, 1997·Lupus·Y KipenE F Morand
Apr 15, 1999·Journal of the American Society of Nephrology : JASN·M A DooleyL A Hebert
Sep 15, 2000·Rheumatology·H C Nossent, W Koldingsnes
Feb 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D I Daikh, D Wofsy
Oct 2, 2002·Annals of Internal Medicine·Yousaf Ali, Samir Shah
Feb 28, 2003·Clinical Rheumatology·M DebandtO Meyer
Apr 18, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Abdullah A Al Salloum
Aug 28, 2003·Southern Medical Journal·Ahmed S Samad, Carol B Lindsley
Oct 25, 2003·Journal of the American Academy of Dermatology·Kapil SaigalFrancisco A Kerdel
Jan 30, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert S FlancRobert C Atkins
Feb 14, 2004·Rheumatology·P P KapitsinouH M Moutsopoulos
Mar 5, 2004·The New England Journal of Medicine·Gabriel ContrerasDavid Roth
Apr 23, 2004·Current Opinion in Rheumatology·R John LooneyInãki Sanz

❮ Previous
Next ❯

Citations

Dec 19, 2012·Indian Journal of Dermatology·Tarun NarangAnureet Kaur
May 23, 2015·Journal of Immunotoxicology·Devon D SominskiDaniel Weinstock
May 17, 2011·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·A García-SabinaR Martínez-Pacheco
Apr 5, 2011·The Canadian Journal of Cardiology·Idan RoifmanJacques Genest
Dec 16, 2010·Journal of Pharmacological and Toxicological Methods·Devon D EgenolfPeter J Bugelski
Dec 19, 2006·Seminars in Cutaneous Medicine and Surgery·Melissa I Costner, Renee H Grau
Apr 12, 2007·Expert Opinion on Pharmacotherapy·Marta MoscaStefano Bombardieri
Oct 5, 2010·International Journal of Toxicology·Peter J BugelskiJacques Descotes
Jun 6, 2009·Nature Reviews. Rheumatology·Joan T Merrill, Jill P Buyon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Autoimmunity Reviews
Sean Gregory O'Neill, Leslie Schrieber
International Immunopharmacology
M MoscaG R Hughes
Arthritis and Rheumatism
Joan T Merrill, Jill P Buyon
© 2021 Meta ULC. All rights reserved